COMMUNICATIONS
tert-Butyl Sulfoxides: Key Precursors for Palladium-Catalyzed Arylation
[5] a) J. S. OꢁDonnell, A. L. Schwan, J. Sulfur Chem. 2004,
25, 183–211; b) A. L. Schwan, ChemCatChem 2015, 7,
226–227.
[6] For recent developments: a) L. Zong, X. Ban, C. W.
Kee, C.-H Tan, Angew. Chem. 2014, 126, 12043–12047;
Angew. Chem. Int. Ed. 2014, 53, 11849–11853; b) S. C.
Sçderman, A. L. Schwan, J. Org. Chem. 2013, 78, 1638–
1649; c) F. Gelat, A.-C. Gaumont, S. Perrio, J. Sulfur
Chem. 2013, 34, 596–605.
[7] a) G. Maitro, S. Vogel, G. Prestat, D. Madec, G. Poli,
Org. Lett. 2006, 8, 5951–5954; b) G. Maitro, S. Vogel,
M. Sadaoui, G. Prestat, D. Madec, G. Poli, Org. Lett.
2007, 9, 5493–5496; for further extensions with hetero-
aryl halides, see: c) F. Colobert, R. Ballesteros-Garrido,
F. R. Leroux, R. Ballesteros, B. Abarca, Tetrahedron
Lett. 2007, 48, 6896–6899; d) B. Abarca, R. Ballesteros,
R. Ballesteros-Garrido, F. Colobert, F. R. Leroux, Tet-
rahedron 2008, 64, 3794–3801.
high synthetic value of the methodology was further
illustrated with extensions to double arylation pro-
cesses and diastereoselective versions with [2.2]PCP
and biaryl derivatives. Future studies in our laborato-
ry are aimed at applying this chemistry in target
asymmetric synthesis.
Experimental Section
General Cross-Coupling Procedure from tert-Butyl
Sulfoxides 1
To a Schlenk tube, under nitrogen, were introduced succes-
sively tert-butylsulfinyl derivative 1 (0.5 mmol, 1 equiv.),
Pd(dba)2 [bis(dibenzyldieneacetone)palladium, 14.4 mg,
0.025 mmol, 0.05 equiv.], Xantphos [9,9-dimethyl-4,5-bis(di-
phenylphosphino)xanthene, 29 mg, 0.05 mmol, 0.1 equiv.],
K3PO4 (212 mg, 1.0 mmol, 2 equiv.), degassed solvent system
and aryl halide (0.6 mmol, 1.2 equiv.). The reaction mixture
was heated and monitored until consumption of starting ma-
terials by TLC. After completion, the mixture was purified
by column chromatography to afford the anticipated sulfox-
ides 2.
[8] E. Bernoud, G. Le Duc, X. Bantreil, G. Prestat, D.
Madec, G. Poli, Org. Lett. 2010, 12, 320–323.
[9] F. Izquierdo, A. Chartoire, S. P. Nolan, ACS Catal.
2013, 3, 2190–2193.
[10] a) T. Jia, A. Bellomo, S. Montel, M. Zhang, K. El Bai-
na, B. Zheng, P. J. Walsh, Angew. Chem. 2014, 126,
264–268; Angew. Chem. Int. Ed. 2014, 53, 260–264;
b) T. Jia, M. Zhang, I. K. Sagamanova, C. Y. Wang, P. J.
Walsh, Org. Lett. 2015, 17, 1168–1171.
[11] Literature precedents involve Pd2(dba)3/Xantphos,
[Pd(i-Pr*)(cin)Cl], Pd(dba)2/NiXantphos and a NiXant-
phos-based palladacycle as catalytic systems. See
refs.[7–10]
[12] A single diastereoselective version for arylation of
sulfenates has been reported. It concerns the use of
a chiral iodoarene. See ref.[7a]
Acknowledgements
We acknowledge financial support from the “Ministre de la
Recherche”, CNRS (Centre National de la Recherche Scienti-
fique) and the “RØgion Basse-Normandie”. ERDF funding
(ISCE-Chem & INTERREG IVa program) and Synorg
Labex are gratefully thanked for financial support.
[13] See, for example: a) J. W. Cubbage, Y. Guo, R. D.
McCulla, W. S. Jenks, J. Org. Chem. 2001, 66, 8722–
8736; b) J. W. A. M. Janssen, H. Kwart, J. Org. Chem.
1977, 42, 1530–1533; c) M. C. Aversa, A. Barattucci,
M. C. Bilardo, P. Bonaccorsi, P. Giannetto, Synthesis
2003, 2241–2248; d) H. Adams, J. C. Anderson, R. Bell,
D. N. Jones, M. R. Peel, N. C. O. Tomkinson, J. Chem.
Soc. Perkin Trans. 1 1998, 3967–3973.
[14] For selected applications from tert-butyl sulfoxides:
a) D. N. Jones, D. R. Hill, D. A. Lewton, C. Sheppard,
J. Chem. Soc. Perkin Trans. 1 1977, 1574–1587; b) M.
Redon, Z. Janousek, H. G. Viehe, Tetrahedron 1997, 53,
15717–15728; c) R. S. Grainger, P. Tisselli, J. W. Steed,
Org. Biomol. Chem. 2004, 2, 151–153; d) S. T. Bedford,
R. S. Grainger, J. W. Steed, P. Tisselli, Org. Biomol.
Chem. 2005, 3, 404–406; e) J. M. Southern, I. A. OꢁNeil,
P. Kearns, Synlett 2008, 2158–2160; f) T. Saiki, K. Goto,
N. Tokitoh, M. Goto, R. Okazaki, J. Organomet. Chem.
2000, 611, 146–157; g) N. Le Fur, L. Mojovic, N. PlØ, A.
Turck, V. Reboul, P. Metzner, J. Org. Chem. 2006, 71,
2609–2612.
References
[1] For reviews: a) B. M. Trost, M. Rao, Angew. Chem. Int.
Ed. 2015, 54, 5026–5043; b) G. E. OꢁMahony, A. Ford,
A. R. Maguire, J. Sulfur Chem. 2013, 34, 301–341; c) E.
´
´
Wojaczynska, J. Wojaczynski, Chem. Rev. 2010, 110,
4303–4356; d) M. C. CarreÇo, G. Hernµndez-Torres, M.
Ribagorda, A. Urbano, Chem. Commun. 2009, 6129–
6144; e) M. Mellah, A. Voituriez, E. Schulz, Chem.
Rev. 2007, 107, 5133–5209; f) G. Sipos, E. E. Drinkel,
R. Dorta, Chem. Soc. Rev. 2015, 44, 3834–3860.
[2] a) M. Y. Putra, A. Ianaro, E. Panza, G. Bavestrello, C.
Cerrano, E. Fattorusso, O. Taglialatela-Scafati, Tetrahe-
dron Lett. 2012, 53, 3937–3939; b) S. W. Meyer, T. F.
Mordhorst, C. Lee, P. R. Jensen, W. Fenical, M. Kçck,
Org. Biomol. Chem. 2010, 8, 2158–2163.
[3] Esomeprazole was the second largest selling drug in
2013 ($6.135 billion U.S.): Top 100 Selling Drugs of
820011 (accessed January 30, 2014).
[15] During the manuscript preparation, Walsh reported the
use of tert-butyl phenyl sulfoxide to provide benzene-
sulfenate: M. Zhang, T. Jia, I. K. Sagamanova, M. A.
Pericµs, P. J. Walsh, Org. Lett. 2015, 17, 1164–1167.
[16] See ref.[5b] and X. Lu, T. E. Long, J. Org. Chem. 2010,
75, 249–252.
[4] H. B. Kagan, Synthesis of Chiral Sulfoxides, in: Organo-
sulfur Chemistry in Asymmetric Synthesis, (Eds: T.
Toru, C. Bolm), Wiley-VCH, Weinheim, 2008, pp 1–29.
Adv. Synth. Catal. 2015, 357, 2011 – 2016
ꢀ 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
2015